Wernicke's encephalopathy: an excitotoxicity hypothesis

被引:8
|
作者
McEntee, WJ
机构
[1] Clinical Studies Ltd., Sarasota, FL 34239
关键词
Wernicke encephalopathy; thiamine deficiency; glutamate; neurotoxicity; excitotoxicity; circumventricular organs;
D O I
10.1023/B:MEBR.0000007099.18010.72
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thiamine deficiency is a recognized cause of Wernicke's encephalopathy (WE), a condition in which small necrotic lesions are found in close proximity to the third and fourth ventricles and the Sylvian aqueduct. Although the neuropathology of WE is well-established, the pathogenic mechanisms that determine the formation and distribution of brain lesions identified with this illness are not understood. It is proposed here that glutamate neurotoxicity causes the brain lesions in WE. Glutamic acid decarboxylase (GAD), an enzyme mainly confined to the central nervous system, protects most regions of the brain from glutamate that accumulates when the activity of or-ketoglutarate dehydrogenase, a thiamine-dependent enzyme complex, is reduced. During severe thiamine deficiency, glutamate accumulates in CAD-free peripheral tissues and reaches a concentration in blood at which it passes through circumventricular organs into the cerebral ventricles or contiguous brain and finally diffuses into the extracellular space of proximate diencephalic and brain stem tissues. Extracellular glutamate eventually reaches neurotoxic levels in those tissues and causes the characteristic lesions of WE.
引用
收藏
页码:183 / 192
页数:10
相关论文
共 50 条
  • [1] Wernicke’s encephalopathy: an excitotoxicity hypothesis
    William J. McEntee
    Metabolic Brain Disease, 1997, 12 (3) : 183 - 192
  • [2] Wernicke's Encephalopathy: an Excitotoxicity Hypothesis
    William J. McEntee
    Metabolic Brain Disease, 1997, 12 : 183 - 192
  • [3] Glutamate-mediated excitotoxicity in Wernicke's encephalopathy
    Hazell, Alan S.
    Vemuganti, Raghu
    Yi, Jae-Hyuk
    Danbolt, Niels C.
    Wang, Chunlei
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2006, 30 (09) : 56A - 56A
  • [4] Wernicke's encephalopathy
    Ramulu, P
    Moghekar, A
    Chaudhry, V
    Zee, DS
    Reich, SG
    NEUROLOGY, 2002, 59 (06) : 846 - 846
  • [5] Wernicke's encephalopathy
    Ploner, M
    Schnitzler, A
    LANCET, 2003, 361 (9362): : 1000 - 1000
  • [6] Wernicke's encephalopathy
    Rosales-Castillo, A.
    Barrero-Hernandez, F. J.
    REVISTA CLINICA ESPANOLA, 2020, 220 (07): : 451 - 452
  • [7] Wernicke's encephalopathy
    Bamber, MG
    LANCET, 1998, 352 (9128): : 655 - 655
  • [8] Wernicke's Encephalopathy
    Patel, Smit
    Topiwala, Karan
    Hudson, Lawrence
    CUREUS, 2018, 10 (08):
  • [9] Wernicke's encephalopathy
    Kaineg, B
    Hudgins, PA
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (19): : E18 - E18
  • [10] Wernicke's Encephalopathy
    Xia, Jikai
    Li, Jun
    NEUROLOGY INDIA, 2023, 71 (03) : 626 - 627